Delivery Order SPE2DB24D2100-SPE2DB24FBBQE
- Not listed
- This federal contract award is for the delivery of ANNOVERA vaginal rings to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has a ceiling value of $1,565.88 and is a firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has an ultimate completion date of June 3, 2024. No set-aside designation is mentioned, indicating this was an open competition. AmerisourceBergen holds a...
- This federal contract award is for the delivery of ANNOVERA vaginal rings to the Defense Logistics Agency (DLA), a defense agency. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2025, with a ceiling value of $48,455.76 and a completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of ANNOVERA vaginal rings to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $2,631.10 and a performance period through March 19, 2024. No set-aside designation was used for this award....
- This federal contract award is for the delivery of ANNOVERA vaginal rings to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, which is a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $1,654.77 and was awarded on a firm fixed price basis by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $2,506.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANNOVERA vaginal rings, with an ultimate completion date of April 11, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This contract was awarded by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp for the delivery of the ANNOVERA vaginal ring product. The contract has a ceiling value of $3,131.76 and a final completion date of July 3, 2024. It is a Firm Fixed Price delivery order contract awarded without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ANNOVERA vaginal rings to the U.S. government. The contract has a ceiling value of $2,783.94 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency supporting the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,506.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANNOVERA vaginal rings, a prescription contraceptive product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and represents open competition....
- This federal contract award, valued at $24,500.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ANNOVERA vaginal rings, a medical product, and is a firm fixed-price delivery order with a completion date of February 25, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ANNOVERA vaginal rings. The contract has a firm fixed price of $2,348.82 and a completion date of May 8, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBBQEDelivery Order
This federal contract award is for the delivery of ANNOVERA vaginal rings to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, with a ceiling value of $6,263.52, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 24, 2024. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as a primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 5/23/24 |